Photopheresis Devices Market: By Product Type (Open System, Closed System), By Disease Indication (Autoimmune diseases, Graft versus host disease, Cutaneous T-cell lymphoma, Transplant rejections), By Distribution Channel (Hospitals, Ambulatory Care, Others) and By Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Photopheresis Devices Market was valued at USD 267.78 million in 2022 and is anticipated to grow at USD 397.35 million by end of 2029 growing at a CAGR of 5.9% during the forecast period 2023-2029.Photopheresis is a form of apheresis in which small amount of the blood is treated with photosensitizing agent. Photopheresis is popular for its therapeutic option used in various autoimmune diseases, organ transplantation such as kidney and liver advanced cutaneous T-cell lymphoma and acute and chronic graft versus host disease (GVHD). U.S. FDA in 1988, has first approved extracorporeal photopheresis (ECP) which is now known as extracorporeal photo immunotherapy, as leukapheresis-based therapeutic procedure.

In Photopheresis, the white blood cells are collected after being exposed to the UVA radiation, 8-MOP. As far as devices of photopheresis are concerned, many open and closed systems available in the market, of which only closed systems are approved by the U.S. FDA due to its lesser risk of contamination, flaws and infection during reinfusion. Photopheresis is a type of photodynamic therapy in which blood is treated with a blood sensitising chemical that has been exposed to a specific wavelength of light. Photopheresis products are in high demand all around the world. The rising incidence of autoimmune illnesses, as well as the rising number of organ transplant cases, are driving the global photopheresis products market. Growing health-care infrastructure, advancements in advanced technology, and an ageing population are all drivers that will propel the market forward.

Photopheresis Devices Market Key Developments:
  • In August 2016, Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, announced that Switzerland's Federal Department of Home Affairs (FDHA) has approved reimbursement of Extracorporeal Photopheresis (ECP) treatment for patients in Switzerland with Bronchiolitis Obliterans Syndrome (BOS) following lung transplantation. Mallinckrodt Pharmaceuticals provides ECP therapy through its THERAKOS therapeutic platforms, including the latest generation THERAKOS CELLEX Photopheresis System 

Photopheresis Devices Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.9%

Largest Market

North America

Fastest Growing Market

Asia-Pacific
Photopheresis Devices Market Dynamics

The increasing prevalence of autoimmune diseases and rising number of organ transplant cases are expected to drive the photopheresis devices market. The safer and effective treatment promised by the introduction of these devices is one of the major factor expected to drives photopheresis devices market. The increased government reimbursement policies and private health insurance is playing a key role in the growth of the market. The awareness about ECP therapy will boost the market. However, the higher cost, time, constant therapy sessions are expected to hinder the market. The availability of lesser number of ECP therapy centers is expected to dampen the market.

Photopheresis Devices Market Segmentation

By Product Type
  • Open System
  • Closed system
By Disease Indication
  • Autoimmune diseases
  • Graft versus host disease
  • Cutaneous T-cell lymphoma
  • Transplant rejections
By Distribution Channel
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Frequently Asked Questions

The Photopheresis Devices Market size was valued at USD 267.78 million in 2022

The Photopheresis Devices Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Asia Pacific is the fastest-growing for Photopheresis Devices Market

Key Features of the Reports

  • The photopheresis devices market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
1.Executive Summary
2.Global Photopheresis Devices Market Introduction 
2.1.Global Photopheresis Devices Market  - Taxonomy
2.2.Global Photopheresis Devices Market  - Definitions
2.2.1.Product Type
2.2.2.Disease Indication
2.2.3.Distribution Channel
2.2.4.Region
3.Global Photopheresis Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Photopheresis Devices Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Photopheresis Devices Market By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Open System
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Closed system
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Photopheresis Devices Market By Disease Indication, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Autoimmune diseases
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Graft versus host disease
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Cutaneous T-cell lymphoma
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Transplant rejections
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Photopheresis Devices Market By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Ambulatory Surgical Centers
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Photopheresis Devices Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Photopheresis Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Open System
9.1.2.Closed system
9.2.  Disease Indication Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Autoimmune diseases
9.2.2.Graft versus host disease
9.2.3.Cutaneous T-cell lymphoma
9.2.4.Transplant rejections
9.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Ambulatory Surgical Centers
9.3.3.Others
9.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Photopheresis Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Open System
10.1.2.Closed system
10.2.  Disease Indication Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Autoimmune diseases
10.2.2.Graft versus host disease
10.2.3.Cutaneous T-cell lymphoma
10.2.4.Transplant rejections
10.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Ambulatory Surgical Centers
10.3.3.Others
10.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11.Asia Pacific (APAC) Photopheresis Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Open System
11.1.2.Closed system
11.2.  Disease Indication Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Autoimmune diseases
11.2.2.Graft versus host disease
11.2.3.Cutaneous T-cell lymphoma
11.2.4.Transplant rejections
11.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Ambulatory Surgical Centers
11.3.3.Others
11.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Photopheresis Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Open System
12.1.2.Closed system
12.2.  Disease Indication Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Autoimmune diseases
12.2.2.Graft versus host disease
12.2.3.Cutaneous T-cell lymphoma
12.2.4.Transplant rejections
12.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Ambulatory Surgical Centers
12.3.3.Others
12.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Photopheresis Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Open System
13.1.2.Closed system
13.2.  Disease Indication Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Autoimmune diseases
13.2.2.Graft versus host disease
13.2.3.Cutaneous T-cell lymphoma
13.2.4.Transplant rejections
13.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Ambulatory Surgical Centers
13.3.3.Others
13.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Macopharma
14.2.2.Haemonetics Corporation
14.2.3.Fresenius Kabi AG
14.2.4.Terumo Corporation
14.2.5.Mallinckrodt Pharmaceuticals
15. Research Methodology 
16. Appendix and Abbreviations 

 

  • Macopharma
  • Haemonetics Corporation
  • Fresenius Kabi AG
  • Terumo Corporation
  • Mallinckrodt Pharmaceuticals

Adjacent Markets